Neurizon inks $1.5M loan against R&D Tax Rebate
Neurizon Therapeutics (ASX:NUZ) retreated in intra-day trade on Wednesday after inking a non-dilutive loan agreement for $1.5 million to fund its current and future operations seeking to treat Huntington’s with its flagship drug NUZ-001.The funds in question are secured against it...
Currently unlisted.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
GEA | Ann: Estimated Annual Distribution Component Information | 08/07/25 | 0 | 117 | |||
|
|||||||
GEA | Ann: Units on Issue Disclosure - June 2025 | 04/07/25 | 0 | 79 | |||
|
|||||||
GEA | Ann: DRP Issue Price | 01/07/25 | 0 | 103 | |||
|
|||||||
GEA | Ann: Final Distribution Announcement | 01/07/25 | 0 | 65 | |||
|
|||||||
GEA | Ann: Estimated Distribution Announcement | 27/06/25 | 0 | 124 | |||
|
|||||||
GEA | Ann: Distribution Timetable | 24/06/25 | 0 | 105 | |||
|
|||||||
GEA | Ann: Units on Issue Disclosure - May 2025 | 05/06/25 | 0 | 123 | |||
|
|||||||
GEA | Ann: Units on Issue Disclosure - April 2025 | 06/05/25 | 0 | 122 | |||
|
See All Discussions
Timeline
![]() |
|
||||
![]() |
|
||||
![]() |
|
||||
![]() |
|
||||
![]() |
|
||||
![]() |
|
||||
View More |